SHI Fan, HOU Yi, ZHAO Jinsong, et al. Preparation of Cyclic Lunasin by Heterologous Recombination Combined with Enzymatic Cyclization and Its Properties[J]. Science and Technology of Food Industry, 2025, 46(7): 133−139. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024040501.
Citation: SHI Fan, HOU Yi, ZHAO Jinsong, et al. Preparation of Cyclic Lunasin by Heterologous Recombination Combined with Enzymatic Cyclization and Its Properties[J]. Science and Technology of Food Industry, 2025, 46(7): 133−139. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024040501.

Preparation of Cyclic Lunasin by Heterologous Recombination Combined with Enzymatic Cyclization and Its Properties

More Information
  • Received Date: May 05, 2024
  • Available Online: February 07, 2025
  • In order to prepare a cyclic polypeptide cLunasin by the method of total biosynthesis, the linear precursor aLunasin was designed for cLunasin synthesis, and a fusion expression vector with the double tags of MBP and SUMO was constructed. After the recombinant expression of aLunasin by Escherichia coli, the cLunasin was catalyzed to synthesize by the polypeptide ligase Butelase 1. The effects of cyclization on the thermal stability, structural properties and anticolorectal cancer activity of the peptide were further investigated by circular dichroism spectroscopy, endogenous fluorescence spectroscopy and cell experiments. The recombinant protein was successfully expressed after induction at 37 ℃, and aLunasin was successfully cyclized by Butelase 1, which was identified by the mass spectrometry identification. And 6.36 mg of cLunasin could be prepared form 1 liter of fermentation broth by the total biosynthesis. Cyclization could get the peptide structure more ordered and more compact, indicated by circular dichroism spectroscopy and endogenous fluorescence spectroscopy. Morover, the thermal stability of peptide was improved after cyclization. After incubation at 97 ℃ for 30 min, the peptide retention for cLunasin increased to 74.9%, while that of Lunasin was 62.3%. The half maximal inhibitory concentration of cLunasin on colorectal cancer HCT-116 cells was determined to 15.2 μmol/L, which was lower than that of for Lunasin 30.3 μmol/L, indicating that the anticolorectal cancer activity was enhanced significantly by cyclization. A green biosynthesis method for cLunasin was established, and an useful exploring was provided for the modification and recombinant expression of active peptides.
  • [1]
    HAO Y Q, FAN X, GUO H M, et al. Overexpression of the bioactive lunasin peptide in soybean and evaluation of its anti-inflammatory and anti-cancer activities in vitro[J]. Journal of Bioscience and Bioengineering,2020,129(4):395−404. doi: 10.1016/j.jbiosc.2019.11.001
    [2]
    HUANG P Y, CHIANG C C, HUANG C Y, et al. Lunasin ameliorates glucose utilization in C2C12 myotubes and metabolites profile in diet-induced obese mice benefiting metabolic disorders[J]. Life Sciences,2023,333:122180. doi: 10.1016/j.lfs.2023.122180
    [3]
    ELVIRA G D, ERICK D, WANG T, et al. Potential health benefits associated with lunasin concentration in dietary supplements and lunasin-enriched soy extract[J]. Nutrients,2021,13(5):1618. doi: 10.3390/nu13051618
    [4]
    SOUZA D, LEDESMA H. Lunasin as a promising plant-derived peptide for cancer therapy[J]. International Journal of Molecular Sciences,2022,23(17):9548. doi: 10.3390/ijms23179548
    [5]
    SZYMC A K, KACZMR W, GAJE K L, et al. Lunasin and its epigenetic impact in cancer chemoprevention[J]. International Journal of Molecular Sciences,2023,24(11):9187. doi: 10.3390/ijms24119187
    [6]
    MESSINA M, CASKILL W, LAMPE J W. Addressing the soy and breast cancer relationship:Review, commentary, and workshop proceedings[J]. Jnci-Journal of the National Cancer Institute,2006,98(18):1275−1284. doi: 10.1093/jnci/djj356
    [7]
    KERWIN S M. Soy saponins and the anticancer effects of soybeans and soy-based foods[J]. Current Medicinal Chemistry Anti-cancer Agents,2004,4(3):263−72. doi: 10.2174/1568011043352993
    [8]
    KHAN N, AFAQ F, MUKHTAR H. Cancer chemoprevention through dietary antioxidants:Progress and promise[J]. Antioxidants and Redox Signaling,2008,10(3):475−510. doi: 10.1089/ars.2007.1740
    [9]
    LOSSO J N. The biochemical and functional food properties of the bowman-birk inhibitor[J]. Critical Reviews in Food Science and Nutrition,2008,48(1):94−118. doi: 10.1080/10408390601177589
    [10]
    MEJIA E G, PRISECARU V I. Lectins as bioactive plant proteins:A potential in cancer treatment[J]. Critical Reviews in Food Science and Nutrition,2005,45(6):425−445. doi: 10.1080/10408390591034445
    [11]
    FAN X, QIN P Y, HAO Y Q, et al. Overexpression of soybean-derived lunasin in wheat and assessment of its anti-proliferative activity in colorectal cancer HT-29 cells[J]. International Journal of Molecular Sciences,2020,21(24):9594. doi: 10.3390/ijms21249594
    [12]
    SAMUEL F T, XU F, HAN Y H, et al. Inhibitory effects of peptide lunasin in colorectal cancer HCT-116 cells and their tumorsphere-derived subpopulation[J]. International Journal of Molecular Sciences,2020,21(2):537. doi: 10.3390/ijms21020537
    [13]
    REYES E D, MEJIA E, PEREA F, et al. Liposomes loaded with unsaponifiable matter from Amaranthus hypochondriacus as a source of squalene and carrying soybean lunasin inhibited melanoma cells[J]. Nanomaterials,2021,11(8):1960. doi: 10.3390/nano11081960
    [14]
    PATERSON S, TOME S, GALVEZ A, et al. Evaluation of the multifunctionality of soybean proteins and peptides in immune cell models[J]. Nutrients,2023,15(5):1220. doi: 10.3390/nu15051220
    [15]
    GULLA K, KARTH A, SHIVA N, et al. Quantification of bioactive peptide lunasin from soybean, wheat, and their commercial products by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry[J]. Journal of Food Measurement and Characterization,2023,17(5):4927−4937. doi: 10.1007/s11694-023-02008-1
    [16]
    ZHAO J S, GE G, HUANG Y B, et al. Butelase 1 mediated enzymatic cyclization of antimicrobial peptides:Improvements on stability and bioactivity[J]. Journal of Agricultural and Food Chemistry,2022,70(50):15869−15878. doi: 10.1021/acs.jafc.2c06588
    [17]
    LIU C F, PAN T M. Recombinant expression of bioactive peptide lunasin in Escherichia coli[J]. Applied Microbiology and Biotechnology,2010,88(1):177−186. doi: 10.1007/s00253-010-2754-5
    [18]
    何佳彧, 梁菊, 宣茂松, 等. 提高多肽体内稳定性的有效策略[J]. 药学学报,2020,55(1):25−32. [HE J Y, LIANG J, XUAN M S, et al. Effective strategies to improve the stability of polypeptides in vivo[J]. Acta Pharmacologica Sinica,2020,55(1):25−32.]

    HE J Y, LIANG J, XUAN M S, et al. Effective strategies to improve the stability of polypeptides in vivo[J]. Acta Pharmacologica Sinica, 2020, 55(1): 25−32.
    [19]
    NI Z F, LI N, XU P, et al. Enhancement of thermostability and catalytic properties of ammonia lyase through disulfide bond construction and backbone cyclization[J]. International Journal of Biological Macromolecules,2022,219:804−811. doi: 10.1016/j.ijbiomac.2022.07.213
    [20]
    NGUYEN G, WANG S, QIU Y, et al. Butelase 1 is an asx-specific ligase enabling peptide macrocyclization and synthesis[J]. Nature Chemical Biology,2014,10(9):732−738. doi: 10.1038/nchembio.1586
    [21]
    SOUZA S, KALUME D, LIMA L, et al. Physicochemical and structural properties of lunasin revealed by spectroscopic, chromatographic and molecular dynamics approaches[J]. BBA Proteins and Proteomics,2020,1868(8):140−154.
    [22]
    SOUZA S, FERRETTI G, KALUME D, et al. Novel method for the production, purification, and characterization of recombinant lunasin:Identification of disulfide cross-linked dimers[J]. International Journal of Peptide Research and Therapeutics,2022,28:159−162. doi: 10.1007/s10989-022-10466-2
    [23]
    GILL H S. Evaluating the efficacy of tryptophan fluorescence and absorbance as a selection tool for identifying protein crystals[J]. Acta Crystallographica Section F-Structural Biology Communications,2010,66(3):364−372. doi: 10.1107/S1744309110002022
    [24]
    BAHAR A A, REN D. Antimicrobial peptides[J]. Pharmaceuticals,2013,6(12):1543−1575. doi: 10.3390/ph6121543
    [25]
    STEWART E J, ASLUND F, BECK J. Disulfide bond formation in the Escherichia coli cytoplasm:An in vivo role reversal for the thioredoxins[J]. Embo Journal,1998,17(19):5543−5550. doi: 10.1093/emboj/17.19.5543
    [26]
    LOBSTEIN J, EMRICH C A, JEANS C, et al. SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm[J]. Microbial Cell Factories,2012,11(56):506−510.
    [27]
    VASSIL A A, KOZLOV S A, GRISHIN E V. Antimicrobial peptide precursor structures suggest effective production strategies[J]. Recent Patents on Inflammation & Allergy Drug Discovery,2008,2(1):58−63.
    [28]
    NGUYEN G K, QIU Y, CAO Y, et al. Butelase-mediated cyclization and ligation of peptides and proteins[J]. Nature Protocols,2016,11(10):1977−1988. doi: 10.1038/nprot.2016.118
    [29]
    MARTIN L A, GONG X, DUSZYK M, et al. The three-dimensional structure of carnocyclin A reveals that many circular bacteriocins share a common structural motif[J]. Journal of Biological Chemistry,2009,284(42):28674−28681. doi: 10.1074/jbc.M109.036459
    [30]
    HUANG L R, ZHANG W X, YAN D D, et al. Solubility and aggregation of soy protein isolate induced by different ionic liquids with the assistance of ultrasound[J]. International Journal of Biological Macromolecules,2020,164:2277−2283. doi: 10.1016/j.ijbiomac.2020.08.031
  • Other Related Supplements

Catalog

    Article Metrics

    Article views (26) PDF downloads (5) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return